Filter
534
Filtered Results: 534
Text search:
XDR-TB
Featured
Recommendations
64
New Publications
140
Language
Document type
No document type
384
Guidelines
45
Studies & Reports
44
Manuals
17
Strategic & Response Plan
13
Situation Updates
12
Fact sheets
9
Training Material
8
Resource Platforms
1
Infographics
1
Countries / Regions
Western and Central Europe
50
Eastern Europe
34
India
22
South Africa
19
Latin America and the Carribbean
15
Kenya
11
Namibia
11
Nepal
9
Tanzania
9
Bangladesh
9
Colombia
8
Uganda
8
Peru
7
Ukraine
6
Asia
6
Germany
6
Russia
6
Ethiopia
6
Myanmar / Burma
6
Global
5
Argentina
5
Senegal
4
Bolivia
4
Botswana
4
Zambia
4
Ecuador
4
Lesotho
3
Ghana
3
Malawi
3
Mozambique
3
Armenia
3
Paraguay
3
Eswatini/ Swaziland
3
Tajikistan
2
El Salvador
2
Sierra Leone
2
Philippines
2
Africa
2
Venezuela
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Turkmenistan
2
Vietnam
2
Brazil
2
Georgia
2
Indonesia
2
Madagascar
2
Timor Leste/ East Timor
1
Gambia
1
Rwanda
1
Kazakhstan
1
Cameroon
1
Nigeria
1
Albania
1
Estonia
1
Afghanistan
1
Cambodia
1
Dominican Republic
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Azerbaijan
1
Belarus
1
East and Southern Africa
1
Moldova
1
Sri Lanka
1
Romania
1
Bhutan
1
South Sudan
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
205
Clinical Guidelines
59
Public Health
12
Capacity Building
9
Pharmacy & Technologies
6
Key Resources
5
Women & Child Health
1
Toolboxes
TB
340
HIV
39
AMR
23
Polio
11
Refugee
8
Caregiver
5
Ebola
4
Pharmacy
4
Rapid Response
3
COVID-19
3
NTDs
3
Specific Hazards
1
Disability
1
Conflict
1
Global Health Education
1
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
Tuberculosis MDR-TB & XDR-TB The 2008 Report
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Le présent manuel fournit les directives actualisées à l'intention des médecins, infirmiers et laborantins confrontés à la tuberculose multirésistante (TB-MR). Il remplace la version élaborée en 2007 et s’est enrichi de l’expérience pratique de six années. Il s’appuie sur les recomm...
Chapter 105
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Chapter 8, Prison and Health, published
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
Revised National Tuberculosis Control Programme
